Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
OCT changes with low-level red light therapy for myopia in children
(Image credit: AdobeStock/Microgen) Zhehuan Zhang, MD, and colleagues from the Department of Ophthalmology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, emphasized the importance of patients undergoing routine optical coherence tomography (OCT) scans during repeated low-level red-light (RLRL)…
The potential of AI in retina with Daniela Ferrara
This conversation features Daniella Ferrara, Chief Medical Officer for TopCon Healthcare, discussing the transformative potential of artificial intelligence in retinal imaging and ophthalmology. Ferrara, an ophthalmologist and retina specialist with 25 years of experience in retinal imaging innovation. The discussion…
Kriya Therapeutics raises $313.3 funding
(Image credit: ©Hand Robot/AdobeStock) Kriya Therapeutics reported in an SEC filing it has raised $313.3 million in a recent funding round.1 The filing does not detail fund specificity or funding sources but rather only states two investors participated in the…
Racial and ethnic disparities in retinoblastoma treatment options
Vivienne S. Hau, MD, PhD, a vitreoretinal surgeon and faculty member at the Bernard J Tyson School of Medicine, Kaiser Permanente Med School, and also at the California University of School of Medicine, presented research on racial and ethnic disparities…
Cannula vs needle in tear trough treatment
(Image Credit: AdobeStock/ME Image) Tear trough filler remains a topic of debate among some surgeons due to concerns about complications such as edema, malar mound accentuation, and vascular compromise. Nonetheless, this treatment has continuously proven to be an effective tool…
European Commission approves aflibercept biosimilar Mynzepli
AVT06, now approved for marketing in the EU as Mynzepli, is also under regulatory review in the United States and Japan. Image credit: ©artjazz – stock.adobe.com Advanz Pharma and Alvotech announced that the European Commission (EC) has approved marketing authorization for…
Nicox releases topline data from phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension patients
(Image Credit: AdobeStock/Naypong Studio) Nicox has announced that the phase 3 Denali trial of NCX 470 0.1% met the primary endpoint of non-inferiority in lowering intraocular pressure (IOP) from baseline in open-angle glaucoma or ocular hypertension patients compared to the…
FDA extends target action date for two Regeneron regulatory submissions to Q4 of 2025
(Image Credit: AdobeStock/Ascannio The US Food and Drug Administration (FDA) has extended the target action dates for Regeneron Pharmaceuticals’ 2 EYLEA HD (aflibercept) Injection 8 mg regulatory submissions to the fourth quarter of 2025. The 2 regulatory submissions include a Chemistry, Manufacturing,…
Associations between androgen exposure, PCOS, and transmasculine individuals with central serous chorioretinopathy
Danny A. Mammo, MD, a vitreoretinal surgeon and uveitis specialist at the Cole Eye Institute at Cleveland Clinic, presented research on the association between androgen exposure and central serous chorioretinopathy (CSCR) at the 2025 scientific meeting of the American Society…
The risk of sight-threatening diabetic retinopathy with GLP-1 RA use
Andy J. Barkmeier, MD, an associate professor of ophthalmology and vitreoretinal surgery at Mayo Clinic in Rochester, Minnesota, presented findings on GLP-1 medications and their relationship to diabetic retinopathy complications at the 2025 ASRS meeting in Long Beach, California. He…